Piramal Pharma Solutions

Piramal Pharma Solutions is a global contract development and manufacturing organization (CDMO) providing end-to-end drug discovery, development, and commercial manufacturing services to pharmaceutical innovators and biotech companies. As a trusted partner in drug substance and drug product manufacturing, the company operates a network of 15 facilities across North America, Europe, and Asia. Its comprehensive service portfolio includes synthetic chemistry, in vitro biology, route scouting, analytical development, and API manufacturing for pre-clinical, clinical, and commercial supply. Piramal Pharma Solutions specializes in complex capabilities such as antibody-drug conjugates (ADCs), high-potency active pharmaceutical ingredients (HPAPIs), sterile injectables, peptides, and oral solid dosages. Additionally, the company provides value-added solutions including regulatory affairs consulting, pharmacovigilance, formulation development, and lifecycle management for drug products. Leveraging extensive regulatory accreditations from the USFDA, EMA, MHRA, and PMDA, Piramal Pharma Solutions supports clients in navigating complex global approval processes. Serving global biotech and pharmaceutical enterprises, the company combines scientific expertise with advanced technology to accelerate life-saving therapies from discovery to commercialization.